基质金属蛋白酶-2导致转移性前列腺癌患者血小板反应性增加：一项初步研究。 - Suppr

Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.

作者信息

Jurasz Paul, North Scott, Venner Peter, Radomski Marek W

机构信息

Department of Medical Oncology, Cross Cancer Institute and Department of Oncology, University of Alberta, Edmonton, AB, Canada T6G 2H7.

出版信息

Thromb Res. 2003;112(1-2):59-64. doi: 10.1016/j.thromres.2003.10.012.

DOI:10.1016/j.thromres.2003.10.012

PMID:15013275

Abstract

摘要

相似文献

Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.

Thromb Res. 2003;112(1-2):59-64. doi: 10.1016/j.thromres.2003.10.012.

Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.

Prostate Cancer Prostatic Dis. 2004;7(4):327-32. doi: 10.1038/sj.pcan.4500750.

Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.

Thromb Haemost. 2007 Mar;97(3):464-70.

Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.

Br J Haematol. 2007 Jul;138(2):221-30. doi: 10.1111/j.1365-2141.2007.06632.x.

Determination of gelatinase A using a modified indirect hemagglutination assay in human prostate cancer screening and assessment of its correlation with prostate-specific antigen parameters.

Int J Urol. 2005 Jul;12(7):637-43. doi: 10.1111/j.1442-2042.2005.01094.x.

Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1570-7. doi: 10.1158/1055-9965.EPI-08-0948. Epub 2009 Apr 21.

MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.

Anticancer Res. 2007 May-Jun;27(3B):1519-25.

[The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients].

Pol Merkur Lekarski. 2007 Jun;22(132):539-41.

Can PSA velocity serve as a surrogate endpoint in trials of hormone-refractory, metastatic prostate cancer?

Nat Clin Pract Urol. 2006 Jun;3(6):310-1. doi: 10.1038/ncpuro0504.

Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.

Eur J Surg Oncol. 2006 Sep;32(7):756-63. doi: 10.1016/j.ejso.2006.03.028. Epub 2006 May 2.

引用本文的文献

Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate Cancer.

Cancers (Basel). 2024 Dec 26;17(1):43. doi: 10.3390/cancers17010043.

Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy.

Front Oncol. 2022 Jun 23;12:909767. doi: 10.3389/fonc.2022.909767. eCollection 2022.

The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.

Int J Mol Sci. 2021 Mar 30;22(7):3608. doi: 10.3390/ijms22073608.

The Platelet Lifeline to Cancer: Challenges and Opportunities.

Cancer Cell. 2018 Jun 11;33(6):965-983. doi: 10.1016/j.ccell.2018.03.002. Epub 2018 Apr 12.

Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.

BMC Cancer. 2015 Sep 9;15:627. doi: 10.1186/s12885-015-1634-x.

Living in shear: platelets protect cancer cells from shear induced damage.

Clin Exp Metastasis. 2014 Aug;31(6):697-704. doi: 10.1007/s10585-014-9660-7. Epub 2014 Jun 19.

Platelets and cancer: a casual or causal relationship: revisited.

Cancer Metastasis Rev. 2014 Mar;33(1):231-69. doi: 10.1007/s10555-014-9498-0.

Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.

Br J Pharmacol. 2012 Jun;166(3):938-49. doi: 10.1111/j.1476-5381.2011.01794.x.

Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.

Br J Pharmacol. 2011 Apr;162(7):1577-89. doi: 10.1111/j.1476-5381.2010.01182.x.

An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study.

BMC Cancer. 2010 Jun 15;10:289. doi: 10.1186/1471-2407-10-289.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献